Sophiris Bio, Inc. Gains 39.96%
Mon, Jan 06, 2020 at 05:30 PM
Sophiris Bio, Inc. (SPHS:NASDAQ) soared at $0.78, representing a gain of 40%. On Fri 03 Jan 20, SPHS:NASDAQ hit a New 2-Week High of $0.56. From Thu 12 Dec 19, the stock recorded 42.86% Up Days and 33.33% Green Days
About Sophiris Bio, Inc. (SPHS:NASDAQ)
Sophiris Bio Inc is a clinical-stage biopharmaceutical company. The Company is engaged in research and development of products for the treatment of urological diseases. It is currently developing PRX302 for treatment of benign prostatic hyperplasia.
Top 10 Gainers:
- CTI Industries Corporation (CTIB:NASDAQ), 225%
- Zion Oil & Gas, Inc. (ZN:NASDAQ), 138.31%
- Pareteum Corporation (TEUM:NASDAQ), 67.15%
- Pareteum Corporation (TEUM:NYSEMKT), 67.15%
- Lilis Energy, Inc. (LLEX:NASDAQ), 44.77%
- Lilis Energy, Inc. (LLEX:NYSEMKT), 44.77%
- Energy Focus, Inc. (EFOI:NASDAQ), 44.23%
- aTyr Pharma, Inc. (LIFE:NASDAQ), 43.43%
- Sophiris Bio, Inc. (SPHS:NASDAQ), 39.96%
- InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ), 37.72%